Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Healthwise HoldingsHKSE:00348 -2.50% Buyback Yield % is 0.00 as of Aug. 23, 2026. The stock has 3 warning signs investors should review. Among 251 Healthcare Providers & Services companies, China Healthwise Holdings ranks worse than 398405.98% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings Buyback Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Healthwise Holdings Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where China Healthwise Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) has a Buyback Yield % of 0.00 as of Aug. 23, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on China Healthwise Holdings and its competitors. According to the industry distribution chart, China Healthwise Holdings ranks #999999 out of 251 companies in the Healthcare Providers & Services industry.
Is China Healthwise Holdings' Buyback Yield % too high?
China Healthwise Holdings' current Buyback Yield % is 0.00. Based on the distribution chart, China Healthwise Holdings ranks #999999 out of 251 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does China Healthwise Holdings' Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, China Healthwise Holdings ranks #999999 out of 251 companies for Buyback Yield %. This places China Healthwise Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on China Healthwise Holdings and its competitors. China Healthwise Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.08 — trading 30% above its estimated fair value. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current Buyback Yield % is 0.00 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00348 has been successfully added to your 
